Please login to be able to save your searches and receive alerts for new content matching your search criteria.
The article is about Exploit Technologies Pte Ltd that is set up by A*STAR to handle the management and commercialization of the researchers' IP.
The Biotechnology Incubation Center of Academia Sinica: A Gateway to Innovative Taiwan.
Cancer Targeting Nanomedicine: An Opportunity for Drug Development in Asia with Emphasis on Taiwan.
Recombinant Lipoproteins for the Development of Novel Subunit Vaccines.
Discovery of Therapeutic Human Monoclonal Antibodies through B-cell Immortalization Technology.